motherlodetv.net
Goldplay Exploration Ltd. (TSXV: GRSL, FRANKFURT: GPE, OTCQB: GLYXF) (“GR Silver” or the “Company”) is pleased to provide drilling results, as well as an update on exploration and current activities at the Company’s San Marcial Silver-Gold Project (“San Marcial”) in Sinaloa, Mexico.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”) is pleased to announce that Executive Co-Chairman and CEO Dr. Raza Bokhari, along with the founders, members of the Company’s Board of Directors, members of the leadership team, early investors, advisors, and other stakeholders, will ring the Nasdaq Stock Market opening bell on Wednesday, January 22, 2020, at 9:30 am ET.
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company”) is pleased to announce it will be exhibiting with Shawn Ryan (Chief Technical Advisor) to provide feature presentations at the upcoming Vancouver Resource Investment Conference and AME Roundup conferences being held January 19 to 23, 2020 in Vancouver, Canada.
Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQB: MLNLF) (“Millennial” or the “Company”) is pleased to announce that the Mining Court of Salta has granted Millennial’s Argentine subsidiary, Proyecto Pastos Grandes S.A., four of the five mining licenses that comprised the original REMSA Properties.
Eloro Resources Ltd. (TSX-V: ELO; FSE: P2Q) (“Eloro”, or the “Company”) is pleased to announce the signing of the Definitive Option Agreement on the Iska Iska polymetallic epithermal project, in the Potosí Department, southern Bolivia by Minera Tupiza S.R.L., Eloro’s wholly-owned Bolivian subsidiary.
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company”) is pleased to announce Rotary Air Blast (RAB) drill results on multiple newly identified drill targets located on the road accessible JP Ross property, in the prolific White Gold District, Yukon, Canada. Generated through the Company’s methodical data driven exploration strategy, the Company’s first ever drilling on these targets was performed as follow up to the previously announced results from 2019 exploration including detailed soil sampling, GT Probe, trenching, geophysical and other prospecting activities. High-grade gold was intercepted of 5 newly identified drill targets located within close proximity to the Company’s Vertigo and Titan discoveries. These targets have unique geochemical signatures and distinct geologic anomalies and include the Stage Fright, North Frenzy, Sabotage, Vertigo and several others. White Gold Corp’s fully-funded $13 million 2019 exploration program backed by partners Agnico Eagle Mines Limited (TSX: AEM, NYSE: AEM) and Kinross Gold Corp (TSX: K, NYSE: KGC) included diamond drilling on the Vertigo target (JP Ross property), Golden Saddle & Arc deposits (White Gold property) as well as soil sampling, prospecting, GT Probe, trenching and RAB/RC drilling on various other properties across the Company’s expansive land package located in the prolific White Gold District, Yukon, Canada.
Goldplay Exploration Ltd. (TSXV: GPLY, FRANKFURT: GPE, OTCQB: GLYXF) (“Goldplay” or the “Company”), is pleased to announce that it will be changing its name to “GR SILVER MINING LTD.” effective Monday, January 13, 2020, to emphasize its focus on more advanced stage silver mining projects in the Rosario Mining District, Mexico.
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”) announced that its Class B Subordinate Voting Shares (the “Shares”) will commence trading on the Nasdaq Capital Market under the symbol ‘HUGE’ today, January 9, 2020. The Company’s Class B Subordinate Voting Shares will continue to trade on the Canadian Securities Exchange under the symbol ‘HUGE’.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced that its Class B Subordinate Voting Shares (the “Shares”) have been approved for listing on the NASDAQ Capital Market (“NASDAQ”) under the symbol ‘HUGE’. Trading on the NASDAQ is expected to commence at market open on Thursday, January 9, 2020.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced the appointments of three key executives: Donal Carroll, Chief Financial Officer. Mr. Carroll previously served as interim CFO; Sandra Lottes, Pharm D, Vice President & Head of Clinical Research of FSD Pharma’s BioSciences Division; and Shahzad Shah, Chief Operating Officer of FV Pharma.